Retatrutide is a 39 amino acid single peptide with triple agonist activity at the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). The backbone is conjugated to a C20 fatty diacid moiety at position 17.
Retatrutide has a Glucose-dependent insulinotropic polypeptide (GIP) peptide backbone, which then contains three non-coded amino acids. Aib2 (α-amino isobutyric acid) residues at positions 2 and 20 provide stability against Dipeptidyl Peptidase 4 (DPP4) cleavage and contribute to GIP activity. αMeL13 (α-methyl-L-leucine)at position 20 also contributes to GIP and glucagon activity.
Retatrutide can be used for the research of obesity obesity, diabetes, and fatty liver disease. It is a works in three ways: stimulating insulin release, suppressing appetite, and promoting fat breakdown.
| Dosage | 5mg single vial,, 5mg 4 vial pack,, 5mg 10 vial pack,, 10mg single vial,, 10mg 4 vial pack,, 10mg 10 vial pack,, 15mg single vial,, 15mg 4 vial pack,, 15mg 10 vial pack |
|---|
© 2024 Created. glp1weightlosspharmacysolution
Reviews
There are no reviews yet.